Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054847 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Licia Bordi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, European Commission, Italian Ministry of Health.
Abstract (Originalsprache)
To compare the detection of the SARS-CoV-2 Omicron variant in nasopharyngeal-swab (NPS) and oral saliva samples. 255 samples were obtained from 85 Omicron-infected patients. SARS-CoV-2 load was measured in the NPS and saliva samples by using Simplexa™ COVID-19 direct and Alinity m SARS-CoV-2 AMP assays. Results obtained with the two diagnostic platforms showed very good inter-assay concordance (91.4 and 82.4% for saliva and NPS samples, respectively) and a significant correlation among cycle threshold (Ct) values. Both platforms revealed a highly significant correlation among Ct obtained in the two matrices. Although the median Ct value was lower in NPS than in saliva samples, the Ct drop was comparable in size for both types of samples after 7 days of antiviral treatment of the Omicron-infected patients. Our result demonstrates that the detection of the SARS-CoV-2 Omicron variant is not influenced by the type of sample used for PCR analysis, and that saliva can be used as an alternative specimen for detection and follow-up of Omicron-infected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
- Clinical and Research Department, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
- Scientific Direction, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
- General and Health Management Direction, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 00149 Rome, Italy.
ORCID-Profile: Giuseppe Sberna, Valentina Mazzotta, Simone Lanini, Angela Corpolongo, Emanuele Nicastri, Enrico Girardi, Andrea Antinori
Förderung
- Ministero della Salute
- European Commission
- Italian Ministry of Health
- European Commission—Horizon 2020
Zitieren
APA
Bordi, L., Sberna, G., Lalle, E., Fabeni, L., Mazzotta, V., Lanini, S., Corpolongo, A., Garbuglia, A. R., Nicastri, E., Girardi, E., Vaia, F., Antinori, A., & Maggi, F. (2023). Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054847
Vancouver
Bordi L, Sberna G, Lalle E, Fabeni L, Mazzotta V, Lanini S, et al. Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054847
BibTeX
@article{Bordi2023,
author = {Bordi, Licia and Sberna, Giuseppe and Lalle, Eleonora and Fabeni, Lavinia and Mazzotta, Valentina and Lanini, Simone and Corpolongo, Angela and Garbuglia, Anna Rosa and Nicastri, Emanuele and Girardi, Enrico and Vaia, Francesco and Antinori, Andrea and Maggi, Fabrizio},
title = {Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054847}
}
EUVIMED